Under way, not recruiting
Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome
NCT06620198 · I.R.C.C.S. Fondazione Santa Lucia · Updated 18 Sept 2026
- What is being tested
- Armeo® Power 2 Exoskeleton - Active Rehabilitation with Feedback and Exercise Gaming; Armeo® Power 2 Exoskeleton - Passive Mobilization without Feedback
- For
- Guillain Barré Syndrome
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 80 years. About 62 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 1 Oct 2024, ends 1 Oct 2027. Registered 1 Oct 2024.
- Results
- None posted yet.
In the researchers' words
Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually. The aim of this double-blind randomized controlled trial with a SHAM control group is to evaluate the effects of robot-assisted therapy, integrated with conventional therapy, on upper limb motor recovery in patients with GBS.
Sites
- IRCCS Santa Lucia FoundationRome, Lazio, Italy